Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Vaccine a plus-$value for Big Pharma...
View:
Post by wildbird1 on Apr 19, 2024 10:46am

Vaccine a plus-$value for Big Pharma...

This is my last post on TLT-vaccine(or maybe not).

In this link...
https://mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/immunotherapy/cancer-vaccines

Under Therapeutic cancer vaccine.
''Therapeutic cancer vaccine expose your immune system to molecules,called antigens(TLT-vaccine work with antigens),that are associated with specific type of cancer.
These vaccines enable the immune system to recognize and destroy the cancer cells''.

''Therapeutic cancer vaccine can:
1) Stop a tumor from growing or spreading.
2) Destroy cancer cells still in the body after a treatment.
3) Keep cancer from coming back after treatment''.

Why is this a plus-value for a Big Pharma(especially no 2-3)?
Let's say a Big Pharma has a cancer treatment that has a 70%CR rate at 90 days, and the CR% rate drop to 25%CR at 450 days.
If this Big Pharma inject TLT(antigens vaccine) after the initial treatment(around 90 days), because of TLT-vaccine the CR% at 450 days could stabilize around 60-70% after 450 days(instead of 25%CR). 

Now! That is what you call a very big plus-$value for any Big Pharma that will sign a deal with TLT.

I love TLT-vaccine.
Comment by menoalittle on Apr 19, 2024 10:54am
>> I love TLT-vaccine.   I'll love anything that gets this darn stock price moving up... lol.
Comment by Alamir1111 on Apr 19, 2024 12:09pm
I'm pretty sure 5 year survival rate is considered free of  disease.So a vaccine would mean that all those high tech laser equipment end up useless  recyclables? ?Man that is another pp to be raised For stage I NHL, the 5-year relative survival rate is more than 86%. For stage II the 5-year relative survival rate is 78%, and for stage III it is more than 72%. For stage IV ...more  
Comment by Alamir1111 on Apr 19, 2024 6:38pm
Let's hope things  work out  and we all be happy. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250